Skip to main content
Earnings Labs
Immatics N.V. logo

Immatics N.V. (IMTX)

NASDAQ·Healthcare·Biotechnology

$8.77

+1.45%

Mkt Cap $1.16B

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (6 analysts)

$25.00

Range $25.00$25.00

Implied Upside

+185.2%

Consensus $25.00 vs current $8.77